The future of biotech innovation may increasingly come from outside traditional industry structures. Around the world, patients and families are becoming agile innovation hubs — identifying unmet needs, building partnerships, influencing policy, and accelerating translational science where the system moves too slowly.
After hearing the word “incurable,” I founded AGO Alliance Poland and began operating as a one-person “pharma company”: connecting researchers, biotech companies, regulators, clinicians, and patient communities to accelerate access to treatments for ultra-rare diseases. Without a lab, corporate infrastructure, or biotech background, I learned to navigate drug development, fundraising, regulatory pathways, and cross-sector collaboration.
This talk explores patient-led innovation as a new force in healthcare and examines what entrepreneurship, systems thinking, and mission-driven leadership look like when time itself becomes the scarcest resource.
- Biotech
- Others
